Stay updated on BOS-580 in NASH Obese Subjects Clinical Trial
Sign up to get notified when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.

Latest updates to the BOS-580 in NASH Obese Subjects Clinical Trial page
- ChecktodayChange DetectedAdded a new revision marker 'Revision: v3.6.6' at the bottom of the page, replacing the previous 'Revision: v3.6.5'. This indicates a minor maintenance update to the page rather than a change to the study data.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now displays an error screen stating that the study record is currently unavailable. The HTML skeleton and site chrome remain visible around the error message instead of showing the study details.SummaryDifference18%

- Check35 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new page build. This appears to be a backend/frontend update rather than a modification to the study data.SummaryDifference0.0%

- Check43 days agoChange DetectedThe study's keyword/subject taxonomy updates from Fatty Liver Disease to Steatotic Liver Disease, representing a metadata-level change. This aligns the terminology with current clinical usage without altering study details or patient-facing content.SummaryDifference0.0%

- Check50 days agoChange DetectedGlaxoSmithKline is now listed as sponsor, replacing Boston Pharmaceuticals and GSK Research and Development Limited, and the study's external identifiers and related dates (301182, BOS-580-201) have been updated to reflect the current record.SummaryDifference0.4%

- Check57 days agoChange DetectedThe page revision label was updated to v3.6.3, indicating a new build of the page. This represents a maintenance/version update rather than a content modification.SummaryDifference0.0%

Stay in the know with updates to BOS-580 in NASH Obese Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.